Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-055900

Options or other derivatives

  • Director acquired 76,760 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Clark William D Director 2025-04-17 Grant or award · Stock Option (Right to Buy) +76,760 76,760 D
Loading xslF345X05/ownership.xml…